You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,799,331

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,799,331 protect, and when does it expire?

Patent 7,799,331 protects FLO-PRED and is included in one NDA.

This patent has eleven patent family members in nine countries.

Summary for Patent: 7,799,331

Patent landscape, scope, and claims:

Title:	Oral suspension of prednisolone acetate
Abstract:	The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
Inventor(s):	Asotra; Satish (Brampton, CA), Gao; Shen (Botton, CA), Yacobi; Avraham (Englewood, NJ)
Assignee:	Taro Pharmaceutical North America, Inc. (Grand Cayman, KY)
Application Number:	11/457,197
Patent Claim Types: see list of patent claims	Composition; Delivery; Use; Dosage form; Formulation;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 7,799,331

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008		DISCN	No	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF ASTHMA	⤷ Subscribe
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008		DISCN	No	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF ALLERGIC REACTIONS	⤷ Subscribe
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008		DISCN	No	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF ALLERGIC REACTIONS	⤷ Subscribe
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008		DISCN	No	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF ASTHMA	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,799,331

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006278620	⤷ Subscribe
Canada	2616112	⤷ Subscribe
China	101247786	⤷ Subscribe
European Patent Office	1909798	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.